Lee Ainslie - Maverick Capital
Holding/activity history for Caribou Biosciences Inc. (CRBU)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 652,542 | 0.02 | $1.96 | ||
| 2024 Q2 | 652,542 | 0.02 | $1.64 | ||
| 2024 Q1 | 652,542 | 0.06 | $5.14 | ||
| 2023 Q4 | 652,542 | 0.08 | $5.73 | ||
| 2023 Q3 | 652,542 | 0.07 | $4.78 | ||
| 2023 Q2 | 652,542 | 0.06 | $4.25 | ||
| 2023 Q1 | 652,542 | 0.09 | $5.31 | ||
| 2022 Q4 | 652,542 | 0.10 | $6.28 | ||
| 2022 Q3 | 652,542 | 0.16 | $10.55 | ||
| 2022 Q2 | 652,542 | 0.09 | $5.43 | ||
| 2022 Q1 | 652,542 | 0.11 | $9.18 | ||
| 2021 Q4 | 652,542 | 0.12 | Reduce 31.49% | 0.06 | $14.94 |
| 2021 Q3 | 952,542 | 0.24 | Buy | 0.24 | $22.87 |